Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

277 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Determinant factors on differences in survival for gastric cancer between the US and Japan using nationwide databases.
Ito Y, Miyashiro I, Ishikawa T, Akazawa K, Fukui K, Katai H, Nunobe S, Oda I, Isobe Y, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Suzuki S, Kakeji Y, Sasako M, Bilchik A, Fujita M; Registration Committee of the Japanese Gastric Cancer Association. Ito Y, et al. Among authors: Sasako M. J Epidemiol. 2020 Apr 11. doi: 10.2188/jea.JE20190351. Online ahead of print. J Epidemiol. 2020. PMID: 32281553 Free article.
Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A.
Sato Y, Mizusawa J, Katayama H, Nakamura K, Fukagawa T, Katai H, Haruta S, Yamada M, Takagi M, Tamura S, Yoshimura T, Tokunaga M, Yoshikawa T, Boku N, Sano T, Sasako M, Terashima M. Sato Y, et al. Among authors: Sasako M. Eur J Surg Oncol. 2020 Mar 4:S0748-7983(20)30145-1. doi: 10.1016/j.ejso.2020.02.038. Online ahead of print. Eur J Surg Oncol. 2020. PMID: 32173178
Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives.
Terashima M, Yoshikawa T, Boku N, Ito S, Tsuburaya A, Iwasaki Y, Fukagawa T, Tokunaga M, Sano T, Sasako M; Stomach Cancer Study Group, Japan Clinical Oncology Group. Terashima M, et al. Among authors: Sasako M. Jpn J Clin Oncol. 2020 May 5;50(5):528-534. doi: 10.1093/jjco/hyaa005. Jpn J Clin Oncol. 2020. PMID: 32134452
Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E, Ito S, Takagi M, Takagane A, Teshima S, Koeda K, Nunobe S, Yoshikawa T, Terashima M, Sasako M. Katai H, et al. Among authors: Sasako M. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):142-151. doi: 10.1016/S2468-1253(19)30332-2. Epub 2019 Nov 19. Lancet Gastroenterol Hepatol. 2020. PMID: 31757656
Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002).
Takahari D, Ito S, Mizusawa J, Katayama H, Terashima M, Sasako M, Morita S, Nomura T, Yamada M, Fujiwara Y, Kimura Y, Ikeda A, Kadokawa Y, Sano T; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Takahari D, et al. Among authors: Sasako M. Gastric Cancer. 2020 Mar;23(2):293-299. doi: 10.1007/s10120-019-01007-w. Epub 2019 Sep 12. Gastric Cancer. 2020. PMID: 31515693
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
Katayama H, Tsuburaya A, Mizusawa J, Nakamura K, Katai H, Imamura H, Nashimoto A, Fukushima N, Sano T, Sasako M. Katayama H, et al. Among authors: Sasako M. Gastric Cancer. 2019 Nov;22(6):1301-1307. doi: 10.1007/s10120-019-00981-5. Epub 2019 Jul 1. Gastric Cancer. 2019. PMID: 31264058 Clinical Trial.
277 results
Jump to page
Feedback